BRAVE: Building Resilience and Values Through E-health
1 other identifier
interventional
56
1 country
1
Brief Summary
The purpose of this study is to determine the feasibility and acceptability of tracking survivors' and their caregivers, stressors, affect, and symptoms using an electronic diary method, in the time period surrounding their routine check- up with their oncologist.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
January 26, 2022
CompletedFirst Posted
Study publicly available on registry
February 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 24, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 24, 2022
CompletedSeptember 13, 2023
September 1, 2023
1.1 years
January 26, 2022
September 10, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Online survey questionnaire
participants will complete a brief online survey every morning and evening within 1 hour of waking and 1 hour of going to sleep
21 days
Study Arms (1)
Daily Diary Method Cohort
OTHERParticipants will be asked to complete a self-report questionnaire that has been validated to assess daily affect. There are 5 items assessing positive affect (joyful, cheerful, happy, lively, proud) and 5 items assessing negative affect (miserable, mad, afraid, scared sad). The respondent is asked to rate these 10 different feelings on a 5-point Likert scale from 1, "not much or not at all" to 5, "a lot."
Interventions
Participants will complete a brief online survey every morning and evening within 1 hour of waking and 1 hour of going to sleep. The surveys will be a combination of measures used to assess affect, stress, and symptoms
Eligibility Criteria
You may qualify if:
- years old
- previously received a pediatric cancer diagnosis and treatment for such
- completed cancer treatment \<5 years ago, in remission
- Own a smart phone or tablet
- are English proficient
You may not qualify if:
- no cognitive, motor, or sensory deficits that could preclude completion of study measures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University
San Francisco, California, 94305, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Claudia Mueller, MD, PhD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2022
First Posted
February 7, 2022
Study Start
March 1, 2021
Primary Completion
March 24, 2022
Study Completion
March 24, 2022
Last Updated
September 13, 2023
Record last verified: 2023-09